Retrophin Inc. (RTRX): Scopia Capital Adds To Its Stake

Page 8 of 12

Page 8 of 12 – SEC Filing

Scopia Management, Inc.
(a) Amount beneficially owned:
3,811,821                                  
(b) Percent of class:
10.4%                                   
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote               0,
(ii) Shared power to vote or to direct the vote 3,811,821,
(iii) Sole power to dispose or to direct the disposition of               0,
(iv) Shared power to dispose or to direct the disposition of 3,811,821.
Matthew Sirovich
(a) Amount beneficially owned:
3,820,571                                  
(b) Percent of class:
10.4%                                   
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote         8,750,
(ii) Shared power to vote or to direct the vote 3,811,821,
(iii) Sole power to dispose or to direct the disposition of         8,750,
(iv) Shared power to dispose or to direct the disposition of 3,811,821.
Jeremy Mindich
(a) Amount beneficially owned:
3,811,821                                  

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)

Page 8 of 12